EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4‐Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers

Arnau Puig-Davi iD, Saul Martinez-Horta iD, Laura Pérez-Carasol, Andrea Horta-Barba, Iñigo Ruiz-Barrio, Ignacio Aracil-Bolaños, Rocío Pérez-González, Elisa Rivas-Asensio, Frederic Sampedro, Antonia Campolongo, Javier Pagonabarraga, Jaime Kulisevsky

Annals of Neurology · 2024

DOI: 10.1002/ana.27035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, 2024. Verfasst von Arnau Puig-Davi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neuroscience, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. Hauptthemen laut MEDLINE: Parkinson Disease, Disease Progression, Cognitive Dysfunction, Magnetic Resonance Imaging. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundació la Marató de TV3, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Cognitive impairment in Parkinson's disease (PD) can show a very heterogeneous trajectory among patients. Here, we explored the mechanisms involved in the expression and prediction of different cognitive phenotypes over 4 years.

Methods

In 2 independent cohorts (total n = 475), we performed a cluster analysis to identify trajectories of cognitive progression. Baseline and longitudinal level II neuropsychological assessments were conducted, and baseline structural magnetic resonance imaging, resting electroencephalogram and neurofilament light chain plasma quantification were carried out. Linear mixed‐effects models were used to study longitudinal changes. Risk of mild cognitive impairment and dementia were estimated using multivariable hazard regression. Spectral power density from the electroencephalogram at baseline and source localization were computed.

Results

Two cognitive trajectories were identified. Cluster 1 presented stability (PD‐Stable) over time, whereas cluster 2 showed progressive cognitive decline (PD‐Progressors). The PD‐Progressors group showed an increased risk for evolving to PD mild cognitive impairment (HR 2.09; 95% CI 1.11–3.95) and a marked risk for dementia (HR 4.87; 95% CI 1.34–17.76), associated with progressive worsening in posterior‐cortical‐dependent cognitive processes. Both clusters showed equivalent clinical and sociodemographic characteristics, structural magnetic resonance imaging, and neurofilament light chain levels at baseline. Conversely, the PD‐Progressors group showed a fronto‐temporo‐occipital and parietal slow‐wave power density increase, that was in turn related to worsening at 2 and 4 years of follow‐up in different cognitive measures.

Interpretation

In the absence of differences in baseline cognitive function and typical markers of neurodegeneration, the further development of an aggressive cognitive decline in PD is associated with increased slow‐wave power density and with a different profile of worsening in several posterior‐cortical‐dependent tasks. ANN NEUROL 2024;96:981–993

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDisease ProgressionCognitive DysfunctionMagnetic Resonance ImagingBiomarkersElectroencephalographyHumansMaleFemaleLongitudinal StudiesAgedMiddle AgedNeurofilament ProteinsNeuropsychological TestsNeuroimagingDementia

Substanzen

BiomarkersNeurofilament Proteinsneurofilament protein L

Autor:innen und Institutionen

  • Institute of Neuroscience, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain.
  • Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.
  • Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), Spain.
  • Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, Alicante, Spain.
  • Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.

ORCID-Profile: Arnau Puig-Davi, Saul Martinez-Horta

Förderung

  • Fundació la Marató de TV3
  • Instituto de Salud Carlos III

Zitieren

APA

Puig-Davi, A., Martinez-Horta, S., Pérez-Carasol, L., Horta-Barba, A., Ruiz-Barrio, I., Aracil-Bolaños, I., Pérez-González, R., Rivas-Asensio, E., Sampedro, F., Campolongo, A., Pagonabarraga, J., & Kulisevsky, J. (2024). Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4‐Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers. Annals of Neurology. https://doi.org/10.1002/ana.27035

Vancouver

Puig-Davi A, Martinez-Horta S, Pérez-Carasol L, Horta-Barba A, Ruiz-Barrio I, Aracil-Bolaños I, et al. Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4‐Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers. Annals of Neurology. 2024. doi:10.1002/ana.27035

BibTeX
@article{PuigDavi2024,
  author = {Puig-Davi, Arnau and Martinez-Horta, Saul and Pérez-Carasol, Laura and Horta-Barba, Andrea and Ruiz-Barrio, Iñigo and Aracil-Bolaños, Ignacio and Pérez-González, Rocío and Rivas-Asensio, Elisa and Sampedro, Frederic and Campolongo, Antonia and Pagonabarraga, Javier and Kulisevsky, Jaime},
  title = {Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4‐Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers},
  journal = {Annals of Neurology},
  year = {2024},
  doi = {10.1002/ana.27035}
}
Kostenlos starten →